drugset / Trial / NCT03406169
Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy
Phase 3
Unknown
180 enrolled
Brooke Army Medical Center
Walter Reed National Military Medical Center · collab
RandomizedSingle-groupTriple-blindTreatment
Summary
The study is a prospective, randomized, double-blind, placebo-controlled drug study to evaluate the pattern of erectile function recovery after robotic assisted laparoscopic prostatectomy (RALP). We hope to illustrate that early and continuous therapy with either Sildenafil citrate or pentoxyfylline after nerve sparing RALP will promote improved erectile function.
Timeline
- Start
- 2017-02-13
- Primary completion
- 2021-12
- Completion
- 2022-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pentoxifylline | Small molecule | 400 mg | — |
| Comparator | Sildenafil | Unknown | 25 mg | Oral |